| Date | Time | Source | Headline | Symbol | Company |
| 11/06/2019 | 5:03PM | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 11/06/2019 | 10:30AM | Edgar (US Regulatory) | Unknown (sec Staff) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 11/06/2019 | 10:30AM | Edgar (US Regulatory) | Unknown (sec Staff) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 08/29/2019 | 4:31PM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 08/29/2019 | 6:46AM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 08/07/2019 | 7:02AM | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 08/07/2019 | 6:44AM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 06/10/2019 | 9:32AM | Edgar (US Regulatory) | Certification by the Exchange Approving Securities for Listing (cert) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 06/07/2019 | 4:56PM | Edgar (US Regulatory) | Securities Registration (section 12(b)) (8-a12b) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 06/07/2019 | 4:41PM | Edgar (US Regulatory) | Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme... | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 06/07/2019 | 4:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 06/07/2019 | 4:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 06/07/2019 | 4:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 06/07/2019 | 4:17PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 06/07/2019 | 4:14PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 06/07/2019 | 4:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 06/07/2019 | 2:20PM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 05/29/2019 | 12:58PM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 05/28/2019 | 4:10PM | GlobeNewswire Inc. | Rexahn Announces Move to Nasdaq | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 05/13/2019 | 8:00AM | GlobeNewswire Inc. | Rexahn Pharmaceuticals Reports First Quarter 2019 Financial Results | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 05/10/2019 | 4:22PM | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 04/29/2019 | 4:45PM | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 04/16/2019 | 8:04AM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 04/16/2019 | 8:00AM | GlobeNewswire Inc. | Rexahn and BioSense Global Announce Collaboration and License Agreement for RX-3117 in Greater China | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 04/12/2019 | 8:16AM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 04/12/2019 | 8:00AM | GlobeNewswire Inc. | Rexahn Effects 1-for-12 Reverse Stock Split | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 04/10/2019 | 4:07PM | GlobeNewswire Inc. | Rexahn Announces Reverse Stock Split | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 03/27/2019 | 8:00AM | GlobeNewswire Inc. | Rexahn Announces Multiple Presentations at the 2019 American Association for Cancer Research Annual Meeting | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 03/26/2019 | 4:15PM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 03/11/2019 | 6:55AM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |